(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.15% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.37%.
Baxter International's revenue in 2026 is $11,611,000,000.On average, 17 Wall Street analysts forecast BAX's revenue for 2026 to be $6,124,885,197,732, with the lowest BAX revenue forecast at $5,928,292,886,292, and the highest BAX revenue forecast at $6,388,215,425,424. On average, 17 Wall Street analysts forecast BAX's revenue for 2027 to be $6,253,704,896,544, with the lowest BAX revenue forecast at $5,989,857,320,664, and the highest BAX revenue forecast at $6,592,567,959,684.
In 2028, BAX is forecast to generate $6,408,392,004,756 in revenue, with the lowest revenue forecast at $6,124,367,849,544 and the highest revenue forecast at $6,835,721,608,044.